Cetera Investment Advisers Amgen Inc Transaction History

Cetera Investment Advisers

  • $44.2 Billion
  • Q3 2024

A detailed history of Cetera Investment Advisers transactions in Amgen Inc stock. As of the latest transaction made, Cetera Investment Advisers holds 199,899 shares of AMGN stock, worth $58.9 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
199,899
Previous 202,748 1.41%
Holding current value
$58.9 Million
Previous $63.3 Million 1.67%
% of portfolio
0.15%
Previous 0.15%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$309.38 - $337.38 $881,423 - $961,195
-2,849 Reduced 1.41%
199,899 $64.4 Million
Q2 2024

Aug 22, 2024
SELL
$262.75 - $319.31 $8.05 Million - $9.78 Million
-30,631 Reduced 13.13%
202,748 $63.3 Million
Q1 2024

May 24, 2024
BUY
$268.87 - $324.56 $49 Million - $59.1 Million
182,197 Added 355.98%
233,379 $66.4 Million
Q1 2024

May 14, 2024
SELL
$268.87 - $324.56 $3.25 Million - $3.92 Million
-12,089 Reduced 19.11%
51,182 $14.6 Million
Q4 2023

Feb 13, 2024
SELL
$255.7 - $288.46 $238,823 - $269,421
-934 Reduced 1.45%
63,271 $18.2 Million
Q3 2023

Nov 14, 2023
BUY
$218.65 - $271.46 $687,872 - $854,013
3,146 Added 5.15%
64,205 $17.3 Million
Q2 2023

Aug 09, 2023
BUY
$214.27 - $253.37 $1.04 Million - $1.23 Million
4,862 Added 8.65%
61,059 $13.6 Million
Q1 2023

May 15, 2023
BUY
$225.79 - $275.2 $686,175 - $836,332
3,039 Added 5.72%
56,197 $13.6 Million
Q4 2022

Feb 14, 2023
SELL
$229.03 - $291.01 $4.99 Million - $6.34 Million
-21,776 Reduced 29.06%
53,158 $14 Million
Q3 2022

Nov 10, 2022
BUY
$224.46 - $253.15 $6.78 Million - $7.65 Million
30,228 Added 67.62%
74,934 $17,000
Q2 2022

Aug 11, 2022
BUY
$230.71 - $256.74 $494,180 - $549,937
2,142 Added 5.03%
44,706 $10.9 Million
Q1 2022

May 13, 2022
BUY
$219.27 - $242.57 $818,973 - $905,998
3,735 Added 9.62%
42,564 $10.3 Million
Q4 2021

Feb 14, 2022
BUY
$198.88 - $227.6 $318,605 - $364,615
1,602 Added 4.3%
38,829 $8.74 Million
Q3 2021

Nov 16, 2021
SELL
$212.27 - $248.7 $611,549 - $716,504
-2,881 Reduced 7.18%
37,227 $7.92 Million
Q2 2021

Aug 13, 2021
BUY
$233.58 - $259.14 $2.53 Million - $2.8 Million
10,819 Added 36.94%
40,108 $9.78 Million
Q1 2021

May 17, 2021
SELL
$221.91 - $258.6 $1.5 Million - $1.75 Million
-6,781 Reduced 18.8%
29,289 $7.29 Million
Q4 2020

Feb 17, 2021
BUY
$216.38 - $257.67 $7.32 Million - $8.71 Million
33,811 Added 1496.72%
36,070 $8.29 Million
Q3 2020

Nov 13, 2020
SELL
$234.65 - $260.95 $9,151 - $10,177
-39 Reduced 1.7%
2,259 $574,000
Q2 2020

Aug 13, 2020
SELL
$197.81 - $242.74 $9,099 - $11,166
-46 Reduced 1.96%
2,298 $542,000
Q1 2020

May 08, 2020
SELL
$182.24 - $241.7 $5,831 - $7,734
-32 Reduced 1.35%
2,344 $475,000
Q4 2019

Feb 10, 2020
BUY
$189.21 - $243.2 $82,873 - $106,521
438 Added 22.6%
2,376 $572,000
Q3 2019

Nov 06, 2019
BUY
$174.11 - $208.62 $53,103 - $63,629
305 Added 18.68%
1,938 $378,000
Q2 2019

Aug 12, 2019
BUY
$166.7 - $195.41 $25,671 - $30,093
154 Added 10.41%
1,633 $302,000
Q1 2019

May 06, 2019
SELL
$180.87 - $203.88 $399,903 - $450,778
-2,211 Reduced 59.92%
1,479 $282,000
Q4 2018

Feb 15, 2019
SELL
$178.4 - $208.25 $65,829 - $76,844
-369 Reduced 9.09%
3,690 $720,000
Q3 2018

Nov 14, 2018
BUY
$185.29 - $208.89 $255,885 - $288,477
1,381 Added 51.57%
4,059 $838,000
Q2 2018

Aug 14, 2018
SELL
$166.05 - $186.51 $24,907 - $27,976
-150 Reduced 5.3%
2,678 $493,000
Q1 2018

May 09, 2018
SELL
$169.43 - $198.0 $143,846 - $168,102
-849 Reduced 23.09%
2,828 $482,000
Q4 2017

Feb 08, 2018
BUY
$168.79 - $188.59 $35,952 - $40,169
213 Added 6.15%
3,677 $637,000
Q3 2017

Nov 16, 2017
BUY
$167.29 - $191.0 $64,573 - $73,726
386 Added 12.54%
3,464 $650,000
Q2 2017

Aug 17, 2017
SELL
N/A
-8,765 Reduced 74.01%
3,078 $529,000
Q2 2017

Aug 14, 2017
BUY
N/A
11,843
11,843 $2.04 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email